-39.8%
COIN vs GSK
+31.2%
-71.1%
-63.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.2% | -1.9% | -2.3% | -4.3% |
| 7D | +3.4% | -1.8% | +5.2% | +3.2% |
| 30D | +23.2% | -2.2% | +25.4% | +23.0% |
| 3M | +12.5% | -1.8% | +14.3% | +12.4% |
| 6M | -11.6% | -10.6% | -1.0% | -13.3% |
| YTD | -18.4% | +4.4% | -22.8% | -16.0% |
| 1Y | -39.8% | +30.4% | -70.2% | -37.8% |
| All | -39.8% | +31.2% | -71.1% | -37.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling